🇦🇹 Austria Country × Condition
uveal melanoma Clinical Trials in Austria
Active clinical trials for uveal melanoma with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT05733728
Recruiting
Retrospective Register for Uveal Melanoma
Enrollment
1,400 pts
Country
🇦🇹 Austria
Medical University of Vienna
View Trial → NCT06007690 Phase 3
Recruiting
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Enrollment
100 pts
Country
🇦🇹 Austria
Aura Biosciences
View Trial → Frequently Asked Questions
How many uveal melanoma clinical trials are active in Austria?
There are currently 2 active clinical trials for uveal melanoma with sites in Austria, of which 2 are actively recruiting patients.
How can I join a uveal melanoma clinical trial in Austria?
To join a uveal melanoma clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are uveal melanoma trials in Austria?
Active uveal melanoma trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology